Downregulation of CHL1 was detected in several types of tumors (such as stomach, rectal, colon, small intestinal, pancreatic, kidney, bladder, breast, thyroid, vulvar, and skin cancer), suggesting that CHL1 might act as a putative tumor suppressor (Senchenko et al., 2011). Here, CHL1 is linked to neoplasm.